State SC
Clinical Trials in South Carolina
Recruiting clinical trials with at least one study location in South Carolina. Data updated daily from ClinicalTrials.gov.
Top Conditions in South Carolina
Frequently Asked Questions — Clinical Trials in South Carolina
How many clinical trials are currently recruiting in South Carolina?
ClinicalMetric currently tracks 188 actively recruiting clinical trials with at least one location in South Carolina. The total number of registered studies—including active but not currently enrolling trials—is 188. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in South Carolina?
South Carolina hosts clinical trials across a broad range of medical conditions, including Asthma, Opioid Use Disorder, Head and Neck Squamous Cell Carcinoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout South Carolina serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in South Carolina?
To join a clinical trial in South Carolina, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in South Carolina maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in South Carolina
NCT06651177 Phase 2
Recruiting
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Op...
Condition
Opioid Use Disorder
Enrollment
310 pts
Location
United States
Sponsor
T. John Winhusen, PhD
NCT05874921 N/A
Recruiting
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Canc...
Condition
Urothelial Carcinoma
Enrollment
400 pts
Location
United States
Sponsor
UroGen Pharma Ltd.
NCT07059325 EARLY_Phase 1
Recruiting
Accelerated TMS for Seizure-Type Functional Neurologic Disorders
Condition
Functional Neurological Symptom Disorder
Enrollment
30 pts
Location
United States
Sponsor
Medical University of South Ca
NCT05766943 N/A
Recruiting
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
Condition
Subcutaneous ICD
Enrollment
71 pts
Location
United States
Sponsor
Medical University of South Ca
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT07325162 N/A
Recruiting
Development of Optical Biometer
Condition
Cataract and IOL Surgery
Enrollment
100 pts
Location
United States
Sponsor
Cassini Technologies
NCT07323654 Phase 2
Recruiting
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Sev...
Condition
Eosinophilic Asthma
Enrollment
264 pts
Location
United States, Serbia, United Kingdom
Sponsor
Kymera Therapeutics, Inc.
NCT06867094 Phase 2
Recruiting
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerat...
Condition
Colitis Ulcerative
Enrollment
204 pts
Location
United States, Argentina, Australia
Sponsor
Sanofi
NCT05654922 Phase 3
Recruiting
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progress...
Condition
Pre-Bronchiolitis Obliterans Syndrome
Enrollment
100 pts
Location
United States
Sponsor
Renovion, Inc.
NCT07195656 N/A
Recruiting
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladd...
Condition
Overactive Bladder (OAB)
Enrollment
151 pts
Location
United States
Sponsor
FemPulse Corporation
NCT04199780 N/A
Recruiting
Effects of tDCS Combined With CBI on Postsurgical Pain
Condition
Total Knee Arthroplasty (Postoperative Pain)
Enrollment
132 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT07040566 Phase 2
Recruiting
A Trial of Varenicline for E-cigarette Cessation
Condition
E-cigarette Use
Enrollment
326 pts
Location
United States
Sponsor
Yale University
NCT06883162 Phase 3
Recruiting
Cannabis-Tobacco Co-Use Treatment Study
Condition
Tobacco Use Disorder
Enrollment
200 pts
Location
United States
Sponsor
Medical University of South Ca
NCT06948422 Phase 3
Recruiting
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension...
Condition
Hypertension
Enrollment
974 pts
Location
United States, Argentina, China
Sponsor
Eli Lilly and Company
NCT06739122 Phase 3
Recruiting
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants W...
Condition
Type 2 Diabetes
Enrollment
55 pts
Location
United States, Argentina, Mexico
Sponsor
Eli Lilly and Company
NCT05489705 N/A
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treat...
Condition
Obstructive Hypertrophic Cardiomyopathy
Enrollment
1,600 pts
Location
United States, Austria, France
Sponsor
Bristol-Myers Squibb
NCT05674409 N/A
Recruiting
Brief Family Involved Treatment Telehealth
Condition
Alcohol Use Disorder
Enrollment
400 pts
Location
United States
Sponsor
Medical University of South Ca
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT07090161 Phase 2
Recruiting
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participan...
Condition
Hypertension
Enrollment
240 pts
Location
United States
Sponsor
Vanda Pharmaceuticals
NCT06534983 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab...
Condition
Muscle-invasive Urothelial Carcinoma
Enrollment
362 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT06052969 N/A
Recruiting
Pulse Endovascular ReperFUSION for Acute Ischemic Stroke
Condition
Acute Ischemic Stroke AIS
Enrollment
8 pts
Location
United States
Sponsor
Euphrates Vascular, Inc.
NCT04970901 Phase 1
Recruiting
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirin...
Condition
B-Cell Non-Hodgkin Lymphoma
Enrollment
200 pts
Location
United States, Belgium, Czechia
Sponsor
ADC Therapeutics S.A.
NCT06807099 N/A
Recruiting
WRAP North America
Condition
Venous Stenosis
Enrollment
250 pts
Location
United States, Canada
Sponsor
Merit Medical Systems, Inc.
NCT06872892 Phase 3
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With B...
Condition
Bronchiectasis
Enrollment
1,755 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT06767683 Phase 2, Phase 3
Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypers...
Condition
Narcolepsy Type 1
Enrollment
256 pts
Location
United States, Australia, Belgium
Sponsor
Alkermes, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology